iSpecimen Past Earnings Performance
Past criteria checks 0/6
iSpecimen's earnings have been declining at an average annual rate of -16.4%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 7.3% per year.
Key information
-16.4%
Earnings growth rate
47.5%
EPS growth rate
| Healthcare Services Industry Growth | 1.7% |
| Revenue growth rate | 7.3% |
| Return on equity | -202.0% |
| Net Margin | -91.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
iSpecimen Inc. (NASDAQ:ISPC) Might Not Be As Mispriced As It Looks After Plunging 32%
Sep 13
US$3.00: That's What Analysts Think iSpecimen Inc. (NASDAQ:ISPC) Is Worth After Its Latest Results
Aug 09Take Care Before Diving Into The Deep End On iSpecimen Inc. (NASDAQ:ISPC)
Jan 04Downgrade: Here's How This Analyst Sees iSpecimen Inc. (NASDAQ:ISPC) Performing In The Near Term
Aug 07Investors Still Aren't Entirely Convinced By iSpecimen Inc.'s (NASDAQ:ISPC) Revenues Despite 33% Price Jump
Apr 18iSpecimen names finance chief Tracy Curley as interim CEO
Sep 22iSpecimen Inc. (NASDAQ:ISPC) Analysts Just Slashed This Year's Estimates
Aug 10iSpecimen GAAP EPS of -$0.30 misses by $0.02, revenue of $2.3M misses by $0.55M
Aug 04iSpecimen Inc.'s (NASDAQ:ISPC) Intrinsic Value Is Potentially 69% Above Its Share Price
Mar 31iSpecimen: High Growth Marketplace At A Discount
Jul 07iSpecimen raises $18M via Nasdaq IPO
Jun 21Revenue & Expenses Breakdown
How iSpecimen makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 10 | -10 | 11 | 4 |
| 30 Jun 24 | 11 | -10 | 12 | 4 |
| 31 Mar 24 | 9 | -12 | 13 | 4 |
| 31 Dec 23 | 10 | -11 | 13 | 4 |
| 30 Sep 23 | 10 | -10 | 13 | 3 |
| 30 Jun 23 | 10 | -11 | 14 | 3 |
| 31 Mar 23 | 11 | -10 | 14 | 3 |
| 31 Dec 22 | 10 | -10 | 13 | 3 |
| 30 Sep 22 | 10 | -10 | 13 | 2 |
| 30 Jun 22 | 10 | -9 | 12 | 2 |
| 31 Mar 22 | 11 | -7 | 11 | 2 |
| 31 Dec 21 | 11 | -9 | 10 | 2 |
| 30 Sep 21 | 11 | -9 | 9 | 2 |
| 30 Jun 21 | 11 | -8 | 8 | 2 |
| 31 Mar 21 | 9 | -7 | 6 | 1 |
| 31 Dec 20 | 8 | -5 | 6 | 1 |
| 30 Sep 20 | 7 | -4 | 5 | 1 |
| 31 Dec 19 | 4 | -5 | 5 | 1 |
| 31 Dec 18 | 4 | -5 | 4 | 1 |
Quality Earnings: ISPC is currently unprofitable.
Growing Profit Margin: ISPC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ISPC is unprofitable, and losses have increased over the past 5 years at a rate of 16.4% per year.
Accelerating Growth: Unable to compare ISPC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ISPC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.9%).
Return on Equity
High ROE: ISPC has a negative Return on Equity (-202.01%), as it is currently unprofitable.